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CASE STUDY
Large pseudoangiomatous stromal 
hyperplasia complicated with gynecomastia 
and lobular differentiation in a male breast
Akiko Mizutou1*, Kazutaka Nakashima1 and Takuya Moriya2
Abstract 
Pseudoangiomatous stromal hyperplasia (PASH) is a benign lesion often observed in parts of the mammary stroma in 
a variety of breast diseases. It is characterized by stromal myofibroblastic proliferation that possesses irregularly anas-
tomosing slit-like pseudovascular spaces lined by a layer of spindle cells. PASH commonly occurs in premenopausal 
women; however, it has also been observed in men with gynecomastia. Although tumor-forming lesions are rare, we 
report on a case with a large PASH in a male breast complicated with gynecomastia. Imaging showed a tumor with a 
diameter of >10 cm in the left breast, and aspiration cytology revealed a benign lesion. Since the tumor was large and 
gradually increased in size, a simple mastectomy was performed. The tumorous lesion was diagnosed as PASH based 
on the pathological and immunohistological findings. It was complicated by gynecomastia with acinar and lobular 
formation, which resembled female mammary gland secretory activity that is observed during lactation.
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Background
Pseudoangiomatous stromal hyperplasia (PASH) is a 
lesion often observed in parts of the mammary stroma in 
a variety of breast diseases. It is a benign lesion formed 
by a stromal myofibroblastic proliferation, possessing 
irregularly anastomosing slit-like pseudovascular spaces 
lined by a layer of spindle cells (Lakhani et  al. 2012). It 
is sometimes observed as an incidental finding, although 
tumor-forming lesions are rare. PASH commonly occurs 
in premenopausal women; however, it has also been 
reported in postmenopausal women undergoing hor-
mone replacement therapy or men with gynecomas-
tia (Badve and Sloane 1995; Milanezi et  al. 1998). It is 
believed that abnormal reactions to hormones by myofi-
broblasts are an important factor in its occurrence (Pow-
ell et al. 1995).
However, gynecomastia is a common disease in male 
breasts. Most patients presenting with gynecomastia will 
have idiopathic, physiological, or secondary gynecomastia 
due to drugs, liver dysfunction, or an endocrine disorder. 
The origin of gynecomastia is thought to be closely related 
to a hormonal imbalance, in which there is a relative excess 
of estrogen compared to androgen (Braunstein 1993). 
Pathological images are characterized by prominent epi-
thelial proliferation in ducts and collagenous stroma; aci-
nar and lobular formation is not usually observed.
We report on a large PASH in a male complicated with 
gynecomastia and lobulation that presented with secre-
tory changes resembling lactation.
Case report
A 50-year-old man had an ulcer on his lower extrem-
ity while receiving outpatient treatment for diabetes 
and dialysis. He was diagnosed with diabetic gangrene 
and arteriosclerosis obliterans of the lower limbs. A left 
breast tumor was discovered upon admission, so he was 
referred to our department. The patient became aware 
of the tumor about 1 year ago, and although it gradually 
increased in size, he never sought medical attention.
A 12  ×  11  cm tumor extended over the entire left 
breast and was palpable. The tumor was elastic, hard, 
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well-defined, and had a smooth surface. No axillary 
lymph node enlargement was observed.
The blood examination before dialysis showed the fol-
lowing: alanine aminotransferase, 2  U/L; aspartate ami-
notransferase, 11  U/L; and γ-glutamyl transpeptidase, 
12  U/L. The hepatitis B antigen and hepatitis C virus 
antibody tests were negative. However, anemia was pre-
sent: red blood cell, 2.48 million/μL; hemoglobin, 7.0   
g/dL; hematocrit, 22.7%; and hemoglobin A1c, 6.8%. The 
kidney function test revealed the following: creatinine, 
8.41  mg/dL; and blood urea nitrogen, 29  mg/dL. The 
patient had no liver dysfunction.
The blood hormone levels before dialysis were as fol-
lows: estradiol (E2), 41 pg/mL (our institution’s reference 
value: 15–35  pg/mL); progesterone, 1.68  ng/mL (0.88–
0.00  ng/mL); testosterone, 3.68  ng/mL (8.71–1.31  ng/
mL); follicle stimulating hormone (FSH), 35.89  mIU/
mL (8.30–2.00  mIU/mL); and prolactin, 76.2  ng/mL 
(12.8–3.6 ng/mL).
Ultrasound showed an oval, well-defined and rough, low-
echo tumor with somewhat of a heterogeneous internal 
echo (Figure  1a). Vascularity was low. Computed tomog-
raphy (CT) showed a well-defined lobular tumor with a 
maximum diameter of 11  cm in the left breast with no 
signs of invasion of the chest wall (Figure 1b, c). Two years 
prior, tumorous lesions could not be confirmed on chest 
CT. Aspiration biopsy cytology showed a small number of 
ductal epithelial cells against a background of stromal cells; 
however, no atypical cells were observed, and a biphasic 
luminal and myoepithelial pattern was maintained. Addi-
tionally, there was an increased cell density of stromal com-
ponents with some presenting with a spindle shape.
A simple mastectomy was performed under general 
anesthesia. The tumor was well-defined with no invasion 
of the surrounding tissue.
Pathologically, the background consisted of gyne-
comastia characterized by epithelial proliferation and 
stromal fibrosis (Figure 2a). Scattered dilated mammary 
ducts were observed, sometimes overlaid by ductal epi-
thelium. Signs of hyperplasia such as papillary prolif-
eration were observed; however, there were no atypical 
cells, and a biphasic pattern was maintained (Figure 2b). 
Moreover, lobular formation was observed in the gyneco-
mastia. In some, the cytoplasm of the acinar epithelium 
exhibited vacuolated changes, resembling female mam-
mary glands during the lactation period (Figure 2a, c, d).
The tumor of the left breast was well-defined, solid, and 
lobular with grayish-white cross sections (Figure 3). Path-
ologically, there was collagenous stromal proliferation 
intermixed with lobular and ductal elements. The stroma 
was dense and contained a pseudoangiomatous structure 
with irregularly anastomosing slit-like spaces. These slit-
like spaces were lined by spindle-shaped cells, which pre-
sented with mild nuclear hypertrophy, but there was no 
nuclear division or atypia (Figure 4a, b).
Immunohistologically, epithelial cells of the tumorous 
area were estrogen receptor (ER) positive and proges-
terone receptive (PR) positive. Spindle cells showed ER 
negative, PR negative, vimentin positive, CD34 positive, 
smooth muscle actin negative, D2-40 negative, CK14 
negative, c-kit negative, and type-IV collagen negative. 
The Ki-67 positive rate of the spindle cells was <5%. 
Therefore, we diagnosed the tumorous area as PASH.
Discussion
In 1986, Vuitch et al. reported on a benign disease pre-
senting with a proliferative lesion of the stroma with 
pseudovascular spaces lined by spindle cells, propos-
ing the concept of pseudoangiomatous hyperplasia of 
mammary stroma (PHMS) (Vuitch et  al. 1986). These 
Figure 1 Imaging examination shows a tumor in the left breast. Ultrasonography shows an oval and low-echo tumor, with a heterogeneous inter-
nal echo, that possessed slit-like spaces (a). Computed tomography shows a well-defined lobular tumor with a maximum diameter of 11 cm in the 
left breast. b Transaxial section; c sagittal section.
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lesions reportedly existed in areas of the stroma, which 
were usually discovered by chance in tissue specimens, 
and they were found in 23% of biopsy and mastectomy 
specimens (Ibrahim et  al. 1989). Later, the term PASH 
was proposed for tumoriform lesions (Powell et al. 1995). 
Lesions that form tumors are also called nodular PASH 
or tumoriform PASH. PASH commonly occurs in pre-
menopausal women (mean age, 37  years) (Powell et  al. 
1995). However, it is also often observed in postmeno-
pausal women undergoing hormone replacement ther-
apy, infants (Shehata et  al. 2009), and men. Particularly, 
in men with gynecomastia, it reportedly exists in 98% 
of PASH cases (Badve and Sloane 1995). Various sizes 
have been reported from 1 to 12 cm (Jaunoo et al. 2011), 
with most being about 3–5 cm. The tumor in our patient 
with macroscopic PASH characteristics had a maximum 
Figure 2 The background demonstrates gynecomastia, characterized by the proliferation of ductal epithelium and stroma (a low-power field). 
There are no atypical cells, and a biphasic pattern is maintained (b high-power field). Lobular formation is observed in the area exhibiting gyneco-
mastia (c low-power field). The acinar cells contain numerous vacuoles, and appeared to exhibit secretory activity during the lactation period  
(d high-power field).
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diameter of 11 cm, but we could find no other reports of 
such a large tumor in a man.
Histologically, there is a mix of ductal components and 
fibrotic stroma, but there is usually lack of atypia. When 
an epithelial lesion is attached, it is often accompanied 
by varying degrees of hyperplasia (Zanella et al. 1998) or 
changes that resemble blunt duct adenosis (Moriya et al. 
2001). The stroma shows irregularly anastomosing spaces 
lined with a layer of spindle cells. The stroma around the 
spaces is formed from a proliferation of hyalinized colla-
gen, which sometimes appears like fibroadenoma entwin-
ing epithelial components (Moriya et  al. 2001). The 
spindle cells resemble vascular endothelial cells, but their 
lumens are void of blood or cellular components, which 
makes them distinguishable from true blood vessels. 
Immunohistologically, the spindle cells are positive for 
vimentin (Ibrahim et al. 1989), positive for smooth mus-
cle actin and CD34 to varying degrees, and are thought 
to be derived from myofibroblasts (Lakhani et  al. 2012; 
Powell et al. 1995; Zanella et al. 1998).
Since this disease is commonly found in premeno-
pausal women, postmenopausal women undergoing 
hormone therapy, patients with a history of taking oral 
contraceptives (Ferreira et  al. 2008), and often in men 
with gynecomastia, its cause is thought to be related to 
hormone imbalances. Specifically, an abnormal myofi-
broblast response to hormones is considered important. 
However, gynecomastia is the enlargement of male mam-
mary glands in response to estrogen (Braunstein 1993). 
It is caused by a hormone imbalance involving a surplus 
of estrogen compared to androgen. Gynecomastia occurs 
in diseases that involve elevated serum estrogen levels, 
such as estrogen-producing tumors and cirrhosis, which 
lead to estrogen metabolism disorders and promotion of 
the production of aromatase due to various reasons. It 
can also occur in states of relatively high estrogen levels 
during anti-androgen therapy for prostate cancer (Kumar 
et al. 2005). Braunstein reported that 25% of gynecomas-
tia cases are idiopathic, 25% are puberty, 10–20% are 
drug-induced, 8% are due to cirrhosis or malnutrition, 8% 
accompany primary hypogonadism, 3% occur with tes-
ticular tumors, 2% have secondary hypogonadism, 1.5% 
Figure 3 The tumor is well-defined, solid, and lobular with grayish-
white cross sections.
Figure 4 Stromal fibrotic proliferation, with anastomosing slit-like pseudovascular spaces, that is lined with spindle cells. a Low-power field; and  
b high-power field.
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have hyperthyroidism, and 1% have renal disease (Braun-
stein 1993). Nagel et al. (1973) reported gynecomastia in 
58% of chronic renal failure and dialysis patients, while 
Vircburger et  al. (1985) reported 42%, which are high 
rates.
The endocrine environment of the hypothalamus-
pituitary–gonadal axis is greatly affected by chronic renal 
failure and dialysis, leading to hypergonadotropic hypo-
gonadism (uremic hypogonadism) (Iglesias et  al. 2012). 
The functions of Leydig cells in the testes of dialysis 
patients are damaged, causing most patients to have low 
testosterone levels, normal to mildly high estrogen levels, 
and normal to high LH/FSH levels. In contrast, an ele-
vated blood prolactin concentration is also reported. This 
kind of endocrine environment is thought to cause gyne-
comastia in dialysis patients. Further, dialysis patients are 
often taking hypotensive agents, anti-gastric ulcer agents, 
and other drugs that can cause drug-induced gynecomas-
tia, which contributes to the situation. Our case exhibited 
slightly high estrogen levels and normal testosterone, 
suggesting a state of elevated estrogen. The patient also 
had a history of internal Ca-blocker and proton pump 
inhibitor administration, both of which affect the prolac-
tin concentration and estrogen/androgen ratio. We sur-
mise that these background factors influenced the onset 
of gynecomastia and the formation of PASH. Moreover, 
a marked rise in the blood prolactin concentration can 
stimulate the mammary glands causing pathological for-
mations, which may have produced the lactation period-
like lobulation—an extremely rare finding.
Mammary glands are derived from the ectoderm. Their 
lumens create mammary ducts during the formation 
and branching of mammary anlagen from the mammary 
ridge. Initially, the breasts are undeveloped in men and 
women, and there are no sex differences until puberty. 
During and after puberty, estrogen causes the mammary 
ducts in women to grow and lengthen, and estrogen and 
progesterone promote differentiation of the lobes and 
acinus. This occurs in the presence of substances such 
as growth hormones, prolactin, and insulin. However, 
male mammary glands never develop. Only a few mam-
mary ducts are found below the nipple, and there is gen-
erally no lobular structure. Gynecomastia also reflects 
the normal, lobeless structure; thus, in histopathological 
findings, a proliferation of ductal epithelium and stromal 
tissue is characteristic, but a lobular structure is usually 
not found. However, lobular formation can be observed 
in male mammary glands due to extraneous hormone 
administration or other causes. An extensive search for 
autopsy cases showed that of 65 gynecomastia cases, 28 
had prostate cancer with a history of estrogen adminis-
tration as a part of hormone therapy. Of these, 8 cases 
(29%) exhibited definite acinus formation, and of those, 
2 showed secretory changes that resembled the lactation 
period in women (Schwartz and Wilens 1963). These two 
cases had no history of taking progesterone. However, 
lactation period-like changes to the mammary glands 
have been reported in a case of sex reversal from male to 
female (Kanhai et al. 2000). This patient underwent hor-
mone therapy, which consisted of progesterone for chem-
ical castration combined with estrogen for feminization.
Although estrogen is deeply involved in the develop-
ment of gynecomastia and in the creation of lactation 
period-like changes in the mammary glands, the involve-
ment of other hormones, including progesterone, andro-
gen, and prolactin cannot be ruled out. In our case, we 
believe that a complex interaction of numerous hor-
mones developed the pathology for PASH complicated 
with gynecomastia and lactation period-like changes.
Regarding prognosis, there have been no reports on 
PASH becoming malignant. The reported recurrence 
rate ranges from 13 to 26% (Gresik et al. 2010), and local 
recurrence is frequent if resection is insufficient. There-
fore, standard treatment is complete resection by wide 
excision. In our case, we performed mastectomy of the 
affected side, and 14 months postoperatively, there were 
no signs of recurrence.
PASH is a lesion mainly in the mammary stroma that 
needs to be differentiated from fibroadenoma, phyllodes 
tumor, and vascular tumors by the presence of vessel-
like spaces. Clinically, these lesions tend to grow and are 
sometimes diagnosed as cancer; therefore, this disease 
should be considered when diagnosing mammary tumors 
in men. Although there are no reports of malignancy, 
patients should be observed closely because of the pos-
sibility of recurrence.
Conclusion
We report on a large PASH in a male breast complicated 
with gynecomastia. It presented acinar and lobular for-
mation in gynecomastia, which simulated female mam-
mary gland secretory activity that is observed during 
lactation.
The tumor of PASH had a maximum diameter of 
11 cm, but we could find no other reports of such a large 
tumor in a man. PASH is commonly found in premeno-
pausal women, but it can be observed in men with gyne-
comastia. It is believed that hormonal imbalance is an 
important factor in its occurrence.
It is an extremely rare finding that PASH complicated 
with gynecomastia and lactation period-like change. A 
history of estrogen administration as a part of hormone 
therapy is observed in most cases with lactation change. 
We believe that a complex interaction of numerous hor-
mones developed the pathology for PASH complicated 
with gynecomastia and lactation period-like changes.
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Clinically, these lesions tend to grow and are some-
times diagnosed as cancer; therefore, this disease should 
be considered when diagnosing mammary tumors in 
men.
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